Keros Therapeutics Announces Leadership Updates

Keros' Board has appointed Jasbir S. Seehra, Ph.D., Chief Executive Officer, as Chair of the Board, effective July 1, 2024. Dr. Seehra will succeed current Chair Carl L. Gordon, Ph.D, C.F.A., who will remain an active Board member. Jean-Jacques Bienaimé will serve as the Lead Independent Director of the Board, effective July 1, 2024. "We're pleased to welcome Jas to the Board Chair position," said Dr. Gordon. "The Board and I have worked closely with and observed Jas in his role as director and as CEO. We b ...